Ryan Specialty (NYSE:RYAN) Research Coverage Started at Royal Bank Of Canada

Royal Bank Of Canada initiated coverage on shares of Ryan Specialty (NYSE:RYAN) in a report issued on Tuesday, Marketbeat reports. The firm issued an outperform rating and a $45.00 price objective on the stock.

RYAN has been the subject of several other reports. UBS Group reduced their price objective on Ryan Specialty from $71.00 to $65.00 and set a “buy” rating for the company in a research note on Tuesday, February 17th. Barclays dropped their target price on Ryan Specialty from $52.00 to $45.00 and set an “overweight” rating on the stock in a report on Wednesday, March 11th. Piper Sandler decreased their price target on shares of Ryan Specialty from $58.00 to $43.00 and set a “neutral” rating for the company in a report on Friday, February 13th. Zacks Research downgraded shares of Ryan Specialty from a “hold” rating to a “strong sell” rating in a research report on Tuesday, February 24th. Finally, Weiss Ratings lowered shares of Ryan Specialty from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Thursday, February 5th. One equities research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating, five have issued a Hold rating and three have given a Sell rating to the company. According to MarketBeat, Ryan Specialty presently has an average rating of “Hold” and a consensus target price of $55.69.

Ryan Specialty Trading Down 0.8%

NYSE RYAN opened at $34.75 on Tuesday. The firm’s 50 day moving average price is $43.38 and its two-hundred day moving average price is $50.60. The company has a debt-to-equity ratio of 2.62, a quick ratio of 0.98 and a current ratio of 0.98. Ryan Specialty has a twelve month low of $33.94 and a twelve month high of $77.16. The stock has a market cap of $9.18 billion, a price-to-earnings ratio of 82.73, a PEG ratio of 0.91 and a beta of 0.65.

Ryan Specialty (NYSE:RYAN) last released its earnings results on Thursday, February 12th. The company reported $0.45 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.05). Ryan Specialty had a net margin of 7.02% and a return on equity of 46.41%. The business had revenue of $751.21 million during the quarter, compared to analysts’ expectations of $777.43 million. During the same quarter in the previous year, the company earned $0.45 EPS. Ryan Specialty’s revenue for the quarter was up 13.2% on a year-over-year basis. Equities analysts anticipate that Ryan Specialty will post 2.29 EPS for the current year.

Ryan Specialty Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 10th. Stockholders of record on Tuesday, February 24th were paid a dividend of $0.13 per share. This is a boost from Ryan Specialty’s previous quarterly dividend of $0.12. The ex-dividend date of this dividend was Tuesday, February 24th. This represents a $0.52 dividend on an annualized basis and a dividend yield of 1.5%. Ryan Specialty’s dividend payout ratio (DPR) is 123.81%.

Insider Activity

In other news, Director Patrick G. Ryan, Jr. purchased 25,500 shares of the stock in a transaction that occurred on Monday, February 23rd. The stock was acquired at an average price of $39.96 per share, with a total value of $1,018,980.00. Following the purchase, the director owned 428,295 shares in the company, valued at $17,114,668.20. This represents a 6.33% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 52.21% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Ryan Specialty

Several hedge funds and other institutional investors have recently added to or reduced their stakes in RYAN. Ameritas Investment Partners Inc. grew its position in Ryan Specialty by 0.9% in the third quarter. Ameritas Investment Partners Inc. now owns 21,119 shares of the company’s stock worth $1,190,000 after acquiring an additional 185 shares in the last quarter. MAI Capital Management raised its holdings in shares of Ryan Specialty by 65.3% during the 2nd quarter. MAI Capital Management now owns 476 shares of the company’s stock valued at $32,000 after purchasing an additional 188 shares in the last quarter. Baker Tilly Wealth Management LLC lifted its stake in shares of Ryan Specialty by 5.6% in the 3rd quarter. Baker Tilly Wealth Management LLC now owns 3,595 shares of the company’s stock valued at $203,000 after purchasing an additional 192 shares during the last quarter. Public Employees Retirement System of Ohio boosted its holdings in Ryan Specialty by 0.6% in the third quarter. Public Employees Retirement System of Ohio now owns 32,797 shares of the company’s stock worth $1,848,000 after purchasing an additional 203 shares in the last quarter. Finally, Covestor Ltd boosted its holdings in Ryan Specialty by 16.8% in the fourth quarter. Covestor Ltd now owns 1,467 shares of the company’s stock worth $76,000 after purchasing an additional 211 shares in the last quarter. Institutional investors own 84.82% of the company’s stock.

Ryan Specialty Company Profile

Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.

Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.